Skip to content
healthcare.dev

TERAZOSIN HYDROCHLORIDE

NDC 24689-002, terazosin hydrochloride, capsule, from Apnar Pharma LP.

Product NDC
24689-002
Status
Listed
Labeler
Apnar Pharma LP
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074823
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/24689-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERAZOSIN HYDROCHLORIDE2 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
24689-002-0124689000201100 CAPSULE in 1 BOTTLE (24689-002-01)
24689-002-10246890002101000 CAPSULE in 1 BOTTLE (24689-002-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/619dd5cb-46fb-4ad9-a05f-f064261a636b

Use it

Look up 24689-002 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/24689-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 24689-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.